Tapinarof Cream Effective For AD, Down to Age 2 Years

Results from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.

Related Keywords

Canada ,Washington ,United States ,American ,Jonathani Silverberg , ,George Washington University ,Journal Of The American Academy Dermatology ,Investigator Global Assessment ,Atopic Dermatitis ,Eczema Area ,Severity Index ,American Academy ,